Institutional and Fund Ownership

SecurityPPHMP / Peregrine Pharmaceuticals, 10.50% Ser E Cumulative Convertible Preferred Stock
President & CEOKING STEVEN W
Institutional Owners3
Institutional Shares426,998
Outstanding Shares37,109,493
Related PPHM / Peregrine Pharmaceuticals, Inc.

Peregrine Pharmaceuticals, 10.50% Ser E Cumulative Convertible Preferred Stock (NASDAQ:PPHMP) has 3 institutional investors that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 426,998 shares. Major holders include Perceptive Advisors Llc , Stafford John S Iii , and Ronin Capital, LLC .


Peregrine Pharmaceuticals, 10.50% Ser E Cumulative Convertible Preferred Stock (NASDAQ:PPHMP) ownership summary shows current positions in the company by institutions and funds, as well as latest changes in position size. Owners can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions.

File DateFormInvestor Opt Prev Shares Current Shares Change
(Percent)
Prev Value (x$1000) Current Value (x$1000) Change
(Percent)
2017-05-15 13F-HR PERCEPTIVE ADVISORS LLC * 200,000 200,000 0.00 3,982 4,342 9.04
2017-07-14 SC 13D/A STAFFORD JOHN S III * 115,299
2017-05-19 SC 13D/A Ronin Capital, LLC * 95,059 111,699 17.50
2017-04-28 13F-HR Burt Wealth Advisors * 600 0 -100.00 12 0 -100.00

Fintel IR - Find the Right Investors for Your Company, Instantly!

Fintel IR combines the comprehensive Fintel ownership database with machine learning to provide advanced tools to make investor outreach fast and easy. Learn more now!


CUSIP: 713661403